Department of Oncological Sciences, Mount Sinai School of Medicine, New York, NY 10029, USA.
Genetics. 2010 May;185(1):81-93. doi: 10.1534/genetics.110.114769. Epub 2010 Mar 1.
The G2 DNA damage checkpoint inhibits Cdc2 and mitotic entry through the dual regulation of Wee1 and Cdc25 by the Chk1 effector kinase. Upregulation of Chk1 by mutation or overexpression bypasses the requirement for upstream regulators or DNA damage to promote a G2 cell cycle arrest. We screened in fission yeast for mutations that rendered cells resistant to overexpressed chk1(+). We identified a mutation in tra1, which encodes one of two homologs of transformation/transcription domain-associated protein (TRRAP), an ATM/R-related pseudokinase that scaffolds several histone acetyltransferase (HAT) complexes. Inhibition of histone deacetylases reverts the resistance to overexpressed chk1(+), suggesting this phenotype is due to a HAT activity, although expression of checkpoint and cell cycle genes is not greatly affected. Cells with mutant or deleted tra1 activate Chk1 normally and are checkpoint proficient. However, these cells are semi-wee even when overexpressing chk1(+) and accumulate inactive Wee1 protein. The changed division response (Cdr) kinases Cdr1 and Cdr2 are negative regulators of Wee1, and we show that they are required for the Tra1-dependent alterations to Wee1 function. This identifies Tra1 as another component controlling the timing of entry into mitosis via Cdc2 activation.
G2 DNA 损伤检查点通过 Chk1 效应激酶对 Wee1 和 Cdc25 的双重调节来抑制 Cdc2 和有丝分裂的进入。Chk1 的突变或过表达上调绕过了上游调节剂或 DNA 损伤的要求,以促进 G2 细胞周期阻滞。我们在裂殖酵母中筛选出能使细胞对过表达的 chk1(+)产生抗性的突变。我们在 tra1 中发现了一个突变,该基因编码转化/转录域相关蛋白(TRRAP)的两个同源物之一,TRRAP 是一种 ATM/R 相关的假激酶,它构成了几个组蛋白乙酰转移酶(HAT)复合物。组蛋白去乙酰化酶的抑制作用使对过表达的 chk1(+)的抗性逆转,这表明这种表型是由于 HAT 活性引起的,尽管检查点和细胞周期基因的表达没有受到很大影响。具有突变或缺失 tra1 的细胞正常激活 Chk1 并且具有检查点功能。然而,这些细胞即使过表达 chk1(+)也具有半 wee 表型,并且积累无活性的 Wee1 蛋白。改变的分裂反应(Cdr)激酶 Cdr1 和 Cdr2 是 Wee1 的负调节剂,我们表明它们是 Tra1 依赖的 Wee1 功能改变所必需的。这表明 Tra1 是另一个通过 Cdc2 激活控制进入有丝分裂时间的组件。